Cargando…

Anti-malarial drug dihydroartemisinin downregulates the expression levels of CDK1 and CCNB1 in liver cancer

Liver cancer is the third leading cause of cancer-associated mortality worldwide. By the time liver cancer is diagnosed, it is already in the advanced stage. Therefore, novel therapeutic strategies need to be identified to improve the prognosis of patients with liver cancer. In the present study, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Liyuan, Li, Shenghao, Peng, Qing, Guo, Yinglin, Ji, Jingmin, Zhang, Zhiqin, Xue, Yu, Liu, Yiwei, Shi, Xinli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299009/ https://www.ncbi.nlm.nih.gov/pubmed/34386075 http://dx.doi.org/10.3892/ol.2021.12914

Ejemplares similares

Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling
por: Yi, You-Cai, et al.
Publicado: (2021)

The Effects of Qinghao-Kushen and Its Active Compounds on the Biological Characteristics of Liver Cancer Cells
por: Ji, Jingmin, et al.
Publicado: (2022)

CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Zou, Yiping, et al.
Publicado: (2020)

CCNB1 and CCNB2 involvement in the pathogenesis of psoriasis: a bioinformatics study
por: Li, An-hai, et al.
Publicado: (2022)

CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysis
por: Li, Qianru, et al.
Publicado: (2019)

MAD1-dependent recruitment of CDK1-CCNB1 to kinetochores promotes spindle checkpoint signaling
por: Alfonso-Pérez, Tatiana, et al.
Publicado: (2019)

Expression and prognostic value of CDK1, CCNA2, and CCNB1 gene clusters in human breast cancer
por: Xing, Zeyu, et al.
Publicado: (2021)

CDK1-CCNB1 creates a spindle checkpoint–permissive state by enabling MPS1 kinetochore localization
por: Hayward, Daniel, et al.
Publicado: (2019)

Requirement for CCNB1 in mouse spermatogenesis
por: Tang, Ji-Xin, et al.
Publicado: (2017)

Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling
por: Hodel, Eva Maria, et al.
Publicado: (2014)

CCNB1 is involved in bladder cancer pathogenesis and silencing CCNB1 decelerates tumor growth and improves prognosis of bladder cancer
por: Wang, Xue-Xuan, et al.
Publicado: (2023)

Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to anti-malarial agent dihydroartemisinin
por: Elf, Shannon, et al.
Publicado: (2016)

Dihydroartemisinin regulates immune cell heterogeneity by triggering a cascade reaction of CDK and MAPK phosphorylation
por: Li, Qilong, et al.
Publicado: (2022)

Association Study of Germline Variants in CCNB1 and CDK1 with Breast Cancer Susceptibility, Progression, and Survival among Chinese Han Women
por: Li, Yan, et al.
Publicado: (2013)

Karyopherin subunit-α 2 expression accelerates cell cycle progression by upregulating CCNB2 and CDK1 in hepatocellular carcinoma
por: Gao, Chun-Lin, et al.
Publicado: (2018)

LINC00346 Acts as a Competing Endogenous RNA Regulating Development of Hepatocellular Carcinoma via Modulating CDK1/CCNB1 Axis
por: Jin, Jinglan, et al.
Publicado: (2020)

Expression of KIF2A, NDC80, CDK1, and CCNB1 in breast cancer patients: Their interaction and linkage with tumor features and prognosis
por: Wang, Cong, et al.
Publicado: (2022)

RalB degradation by dihydroartemisinin induces autophagy and IFI16/caspase-1 inflammasome depression in the human laryngeal squamous cell carcinoma
por: Shi, Xinli, et al.
Publicado: (2020)

ISL1, a novel regulator of CCNB1, CCNB2 and c-MYC genes, promotes gastric cancer cell proliferation and tumor growth
por: Shi, Qiong, et al.
Publicado: (2016)

Ubiquitin-specific protease 22 is a deubiquitinase of CCNB1
por: Lin, Zhenghong, et al.
Publicado: (2015)

Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapy
por: Lemke, Dieter, et al.
Publicado: (2016)

Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-κB/GLUT1 axis
por: Jiang, Jie, et al.
Publicado: (2016)

Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing CCNB1 expression
por: Li, Min, et al.
Publicado: (2021)

Perceptions and utilization of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine in young children in the Chikhwawa District of Malawi: a mixed methods study
por: Ewing, Victoria L, et al.
Publicado: (2015)

Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018
por: Gansané, Adama, et al.
Publicado: (2021)

Role of CCNB1, CENPF, and neutrophils in lung cancer diagnosis and prognosis
por: Tan, Feixiang, et al.
Publicado: (2023)

Mutations in CCNB3 affect its location thus causing a multiplicity of phenotypes in human oocytes maturation by aberrant CDK1 activity and APC/C activity at different stages
por: Wang, Congjing, et al.
Publicado: (2023)

Evolution of genetic markers for drug resistance after the introduction of dihydroartemisinin–piperaquine as first-line anti-malarial treatment for uncomplicated falciparum malaria in Indonesia
por: Rahmasari, Farindira Vesti, et al.
Publicado: (2023)

Dihydroartemisinin induces autophagy-dependent death in human tongue squamous cell carcinoma cells through DNA double-strand break-mediated oxidative stress
por: Shi, Xinli, et al.
Publicado: (2017)

Single-cell, single-mRNA analysis of Ccnb1 promoter regulation
por: Vishnoi, Nidhi, et al.
Publicado: (2017)

Identification and verification of CCNB1 as a potential prognostic biomarker by comprehensive analysis
por: Zeng, Yinzhen, et al.
Publicado: (2022)

Enantiomerically pure amino-alcohol quinolines: in vitro anti-malarial activity in combination with dihydroartemisinin, cytotoxicity and in vivo efficacy in a Plasmodium berghei mouse model
por: Mullié, Catherine, et al.
Publicado: (2014)

Transcription Factor STOX1A Promotes Mitotic Entry by Binding to the CCNB1 Promotor
por: van Abel, Daan, et al.
Publicado: (2012)

CCNB1 Expedites the Progression of Cervical Squamous Cell Carcinoma via the Regulation by FOXM1
por: Li, Shufeng, et al.
Publicado: (2020)

A pancancer analysis of the oncogenic role of cyclin B1 (CCNB1) in human tumors
por: Dai, Peng, et al.
Publicado: (2023)

The analgesic and antidepressant properties of dihydroartemisinine in the neuropathic pain mice: By the downregulation of HnRNPA1 in the spinal cord and hippocampus
por: Zhu, Chunyan, et al.
Publicado: (2022)

HnRNPR-CCNB1/CENPF axis contributes to gastric cancer proliferation and metastasis
por: Chen, Er-Bao, et al.
Publicado: (2019)

Rare Case of BCOR::CCNB3 Sarcoma of Bone
por: Arai, Yumi, et al.
Publicado: (2023)

Correlation between anti-malarial and anti-haemozoin activities of anti-malarial compounds
por: Tam, Dao Ngoc Hien, et al.
Publicado: (2020)

Bioinformatics Analysis Highlight Differentially Expressed CCNB1 and PLK1 Genes as Potential Anti-Breast Cancer Drug Targets and Prognostic Markers
por: Fang, Leiming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2o1lfvdumhr0vtq5fbbsdsbmph